It is so hard to comprehend how the share-price could reach 63c with not one of these groundbreaking therapies, and yet with them in ph1 human trials the shareprice languishes at under 4c.
A
1. I suspect not a lot of holders ( large and small ) really understand the fundamental differences in the various therapies that are available .
2. The complex requirements set down by the FDA in trialing new things make the real selection of candidates quite difficult , as there a lot of situations that exclude "possible candidates " ..... because of the need to prove measurable and statistically acceptable Data . - Thus very long time frames
3. Meanwhile the spectators get bored .... the selling pressure mounts etc etc etc and what was originally hope and enthusiasm gets turned to cynicism & suspicion ...added to that is highly liquid nature of IMU due to the SOI means there's plenty to do trading the volatility and making some good bucks along the way
4. Also ... I'm actually wondering how many really consider the potential of IMU's ground breaking therapies under development and what that longer term value proposition might look like ( because from what I understand nothing has changed on that front ....... )
IMU Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)